Home
Aspect Biosystems

Aspect Biosystems Market Share Analysis for February 2026

We apply our full-stack tissue therapeutic platform to create implantable tissues that could transform the treatment of serious metabolic and endocrine diseases.

Science and Education > Biology

Domainaspectbiosystems.com

Year Founded2013

Employees51 - 200

Annual Revenue$10M - $15M

Aspect Biosystems

Aspect Biosystems (including company regionals)

aspectbiosystems.com

See more website traffic and engagement information

Aspect Biosystems Revenue up to February 2026 is 10M - 15M

revenue generated by Aspect Biosystems top domains

Aspect Biosystems top domains revenue over 3 years

Revenue for Aspect Biosystems top domains

aspectbiosystems.com10M - 15M

See more with Sales Intelligence

Total visits to Aspect Biosystems's top domains

Understand Aspect Biosystems market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

aspectbiosystems.com11.8K

See more with Sales Intelligence

Avg. visit duration in Aspect Biosystems's top domains

Analyze Aspect Biosystems engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

aspectbiosystems.com00:01:11

See more with Sales Intelligence

Avg. pageviews on Aspect Biosystems's top domains

See how Aspect Biosystems keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

aspectbiosystems.com2.81

See more with Sales Intelligence

Aspect Biosystems top competitors by domain

Top similar sites in February 2026, ranked by their affinity

cellink.comCompany NameCELLINK ABEmployees201 - 500HQSweden, GothenburgAnnual revenue$25M - $50MTotal visits41.8KScience and Education > Biology

Top technologies used by Aspect Biosystems

These are the website technologies, by industry, used by Aspect Biosystems top domains

Advertising (7)

Google Adsense

Social (7)

Instagram

Marketing (4)

Google Marketing Platform

Payment & Currencies (4)

Visa

More Technologies

11

See all

News & Signals from Aspect Biosystems

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAspect Biosystems Ltd. is developing advanced cellular medicines for diabetes on Jul 1st '23.Since 2023, Aspect and Novo Nordisk have collaborated to develop cellular medicines designed to replace, repair or supplement biological functions to deliver truly disease-modifying therapies.

NewsAspect Biosystems Ltd. partnered with Maastricht University on Jul 1st '19.In 2019, bioprinting technology company Aspect Biosystems partnered with Maastricht University to advance bioprinted kidney tissue by installing its RX1 microfluidic bioprinter in the Moroni Lab at the MERLN Institute.

NewsAspect Biosystems Ltd. attended event ENDO 2025 on Jul 1st '25.At ENDO 2025 (12-15 July; San Francisco, CA, USA), Aspect Biosystems (Vancouver, Canada) presented preclinical data demonstrating that the company's bioprinted tissue therapeutics (BTTs) can restore adrenal function in animal models of primary adrenal insufficiency.